Cargando…
COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Currently, there is limited knowledge of dysregulation of cellular proliferation and apoptosis that contribute to the malignant phenotype in HCC. Copper metabolism gene MURR1 domain 10 (COMMD10) is i...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093973/ https://www.ncbi.nlm.nih.gov/pubmed/34047468 http://dx.doi.org/10.1002/ctm2.403 |
_version_ | 1783687926508421120 |
---|---|
author | Yang, Mi Wu, Xixi Li, Lu Li, Shaoqun Li, Nan Mao, Mengyuan Pan, Suming Du, Richang Wang, Xiaoqing Chen, Min Xiao, Nanjie Zhu, Xiaohui He, Guoyang Zhang, Longshan Huang, Weiqiang Pan, Hua Deng, Lan Chen, Longhua Liang, Li Guan, Jian |
author_facet | Yang, Mi Wu, Xixi Li, Lu Li, Shaoqun Li, Nan Mao, Mengyuan Pan, Suming Du, Richang Wang, Xiaoqing Chen, Min Xiao, Nanjie Zhu, Xiaohui He, Guoyang Zhang, Longshan Huang, Weiqiang Pan, Hua Deng, Lan Chen, Longhua Liang, Li Guan, Jian |
author_sort | Yang, Mi |
collection | PubMed |
description | BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Currently, there is limited knowledge of dysregulation of cellular proliferation and apoptosis that contribute to the malignant phenotype in HCC. Copper metabolism gene MURR1 domain 10 (COMMD10) is initially identified as a suppressor gene in the pathogenesis of HCC in our observations. Here we aimed to explore its function and prognostic value in the progression of HCC. METHODS: Functional experiments were performed to explore the role of COMMD10 in HCC. The molecular mechanisms of COMMD10 were determined by luciferase assay, immunofluorescence, and immunoprecipitation. The nomogram was based on a retrospective and multicenter study of 516 patients who were pathologically diagnosed with HCC from three Chinese hospitals. The predictive accuracy and discriminative ability of the nomogram were determined by a C‐index and calibration curve and were compared with COMMD10 and the Barcelona Clinic Liver Cancer (BCLC) staging system. The primary endpoint was overall survival (OS). RESULTS: COMMD10 expression was significantly lower in HCC than that in normal liver tissues. In vitro and in vivo experiments revealed that COMMD10 suppressed cell proliferation and induced apoptosis in HCC. Mechanistically, COMMD10 inhibits TNFα mediated ubiquitination of IκBα and p65 nuclear translocation through the combination of COMMD10‐N terminal to the Rel homology domain of p65, which inhibited NF‐κB activity and increased expression of cleaved caspase9/3 in HCC. Clinically, COMMD10 stratifies early‐stage HCC patients into two risk groups with significantly different OS. Additionally, the nomogram based on COMMD10 and BCLC stage yielded more accuracy than BCLC stage alone for predicting OS of HCC patients in three cohorts. CONCLUSIONS: COMMD10 suppresses proliferation and promotes apoptosis by inhibiting NF‐κB signaling and values up BCLC staging in predicting OS, which provides evidence for the identification of potential therapeutic targets and the accurate prediction of prognosis for patients with HCC. |
format | Online Article Text |
id | pubmed-8093973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80939732021-05-10 COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma Yang, Mi Wu, Xixi Li, Lu Li, Shaoqun Li, Nan Mao, Mengyuan Pan, Suming Du, Richang Wang, Xiaoqing Chen, Min Xiao, Nanjie Zhu, Xiaohui He, Guoyang Zhang, Longshan Huang, Weiqiang Pan, Hua Deng, Lan Chen, Longhua Liang, Li Guan, Jian Clin Transl Med Research Articles BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Currently, there is limited knowledge of dysregulation of cellular proliferation and apoptosis that contribute to the malignant phenotype in HCC. Copper metabolism gene MURR1 domain 10 (COMMD10) is initially identified as a suppressor gene in the pathogenesis of HCC in our observations. Here we aimed to explore its function and prognostic value in the progression of HCC. METHODS: Functional experiments were performed to explore the role of COMMD10 in HCC. The molecular mechanisms of COMMD10 were determined by luciferase assay, immunofluorescence, and immunoprecipitation. The nomogram was based on a retrospective and multicenter study of 516 patients who were pathologically diagnosed with HCC from three Chinese hospitals. The predictive accuracy and discriminative ability of the nomogram were determined by a C‐index and calibration curve and were compared with COMMD10 and the Barcelona Clinic Liver Cancer (BCLC) staging system. The primary endpoint was overall survival (OS). RESULTS: COMMD10 expression was significantly lower in HCC than that in normal liver tissues. In vitro and in vivo experiments revealed that COMMD10 suppressed cell proliferation and induced apoptosis in HCC. Mechanistically, COMMD10 inhibits TNFα mediated ubiquitination of IκBα and p65 nuclear translocation through the combination of COMMD10‐N terminal to the Rel homology domain of p65, which inhibited NF‐κB activity and increased expression of cleaved caspase9/3 in HCC. Clinically, COMMD10 stratifies early‐stage HCC patients into two risk groups with significantly different OS. Additionally, the nomogram based on COMMD10 and BCLC stage yielded more accuracy than BCLC stage alone for predicting OS of HCC patients in three cohorts. CONCLUSIONS: COMMD10 suppresses proliferation and promotes apoptosis by inhibiting NF‐κB signaling and values up BCLC staging in predicting OS, which provides evidence for the identification of potential therapeutic targets and the accurate prediction of prognosis for patients with HCC. John Wiley and Sons Inc. 2021-05-04 /pmc/articles/PMC8093973/ /pubmed/34047468 http://dx.doi.org/10.1002/ctm2.403 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Yang, Mi Wu, Xixi Li, Lu Li, Shaoqun Li, Nan Mao, Mengyuan Pan, Suming Du, Richang Wang, Xiaoqing Chen, Min Xiao, Nanjie Zhu, Xiaohui He, Guoyang Zhang, Longshan Huang, Weiqiang Pan, Hua Deng, Lan Chen, Longhua Liang, Li Guan, Jian COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma |
title | COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma |
title_full | COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma |
title_fullStr | COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma |
title_full_unstemmed | COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma |
title_short | COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma |
title_sort | commd10 inhibits tumor progression and induces apoptosis by blocking nf‐κb signal and values up bclc staging in predicting overall survival in hepatocellular carcinoma |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093973/ https://www.ncbi.nlm.nih.gov/pubmed/34047468 http://dx.doi.org/10.1002/ctm2.403 |
work_keys_str_mv | AT yangmi commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT wuxixi commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT lilu commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT lishaoqun commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT linan commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT maomengyuan commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT pansuming commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT durichang commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT wangxiaoqing commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT chenmin commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT xiaonanjie commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT zhuxiaohui commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT heguoyang commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT zhanglongshan commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT huangweiqiang commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT panhua commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT denglan commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT chenlonghua commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT liangli commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma AT guanjian commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma |